1.
Leichsenring F, Leibing E, Kruse J, New AS, Leweke F: Borderline personality disorder. Lancet 2011;377:74-84.
2.
Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K: Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2012;8:CD005652.
3.
Clarkin JF, Yeomans FE, Kernberg OF: Psychotherapy for Borderline Personality. Focusing on Object Relations. Arlington, American Psychiatric Publishing, 2006.
4.
George C, Kaplan N, Main M: The Adult Attachment Interview (unpubl. manuscript). Berkeley, University of California at Berkeley, 1985.
5.
Main M, Goldwyn R: Adult Attachment Scoring and Classification System, version 6.0 (unpubl. manuscript). Berkeley, University of California at Berkeley, 1998.
6.
Taylor P, Rietzschel J, Danquah A, Berry K: Changes in attachment representations during psychological therapy. Psychother Res 2014;25:222-238.
7.
Bakermans-Kranenburg MJ, van IJzendoorn MH: The first 10,000 Adult Attachment Interviews: distributions of adult attachment representations in clinical and non-clinical groups. Attach Hum Dev 2009;11:223-263.
8.
Joubert D, Webster L, Hackett RK: Unresolved attachment status and trauma-related symptomatology in maltreated adolescents: an examination of cognitive mediators. Child Psychiatry Hum Dev 2012;43:471-483.
9.
Doering S, Hörz S, Rentrop M, Fischer-Kern M, Schuster P, Benecke C, Buchheim A, Martius P, Buchheim P: Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomized controlled trial. Br J Psychiatry 2010;196:389-395.
10.
Fischer-Kern M, Doering S, Taubner S, Hörz S, Zimmermann J, Rentrop M, Schuster P, Buchheim P, Buchheim A: Transference-focused psychotherapy for borderline personality disorder: change in reflective function. Br J Psychiatry 2015;2:173-174.
11.
Levy KN, Meehan KB, Kelly KM, Reynoso JS, Weber M, Clarkin JF, Kernberg OF: Change in attachment patterns and reflective function in a randomized control trial of transference-focused psychotherapy for borderline personality disorder. J Consult Clin Psychol 2006;74:1027-1040.
12.
Wittchen HU, Zaudig M, Fydrich T: Structured Clinical Interview for DSM-IV, Axis I and II. Göttingen, Hogrefe, 1997.
13.
Clarkin JF, Caligor E, Stern B, Kernberg OF: Structured Interview of Personality Organization (STIPO). New York, Weill Medical College of Cornell University, 2004.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.